Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer cell

Showing results (371-380 of 4,097) with videos related to

Pageof 410
Sort By:
Cancer Cell|December 12, 2003
Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissueHuiling Liang, Qin Chen, Andrew H Coles, et al.
Cancer Cell|October 31, 2003
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agentsDavid F Stojdl, Brian D Lichty, Benjamin R tenOever, et al.
Cancer Cell|November 13, 2007
Role of nucleosomal occupancy in the epigenetic silencing of the MLH1 CpG islandJoy C Lin, Shinwu Jeong, Gangning Liang, et al.
Cancer Cell|November 13, 2007
Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoproteinFrancesco Fazi, Serena Racanicchi, Giuseppe Zardo, et al.
Cancer Cell|November 13, 2007
Rac guanosine triphosphatases represent integrating molecular therapeutic targets for BCR-ABL-induced myeloproliferative diseaseEmily K Thomas, Jose A Cancelas, Hee-Don Chae, et al.
Cancer Cell|October 16, 2007
PI3 kinase activation and response to Trastuzumab Therapy: what's neu with herceptin resistance?Ben Ho Park, Nancy E Davidson
Cancer Cell|October 16, 2007
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancerKatrien Berns, Hugo M Horlings, Bryan T Hennessy, et al.
Cancer Cell|July 5, 2008
A novel role for a familiar protein in apoptosis induced by proteasome inhibitionDavid J McConkey
Cancer Cell|July 5, 2008
Deregulating EMT and senescence: double impact by a single twistMarjon A Smit, Daniel S Peeper
Cancer Cell|July 5, 2008
In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell propertiesChristoph le Viseur, Marc Hotfilder, Simon Bomken, et al.
Pageof 410

Showing results (371-380 of 4,097) with videos related to

Sort By:
Pageof 410
Cancer Cell|December 12, 2003
Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissueHuiling Liang, Qin Chen, Andrew H Coles, et al.
Cancer Cell|October 31, 2003
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agentsDavid F Stojdl, Brian D Lichty, Benjamin R tenOever, et al.
Cancer Cell|November 13, 2007
Role of nucleosomal occupancy in the epigenetic silencing of the MLH1 CpG islandJoy C Lin, Shinwu Jeong, Gangning Liang, et al.
Cancer Cell|November 13, 2007
Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoproteinFrancesco Fazi, Serena Racanicchi, Giuseppe Zardo, et al.
Cancer Cell|November 13, 2007
Rac guanosine triphosphatases represent integrating molecular therapeutic targets for BCR-ABL-induced myeloproliferative diseaseEmily K Thomas, Jose A Cancelas, Hee-Don Chae, et al.
Cancer Cell|October 16, 2007
PI3 kinase activation and response to Trastuzumab Therapy: what's neu with herceptin resistance?Ben Ho Park, Nancy E Davidson
Cancer Cell|October 16, 2007
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancerKatrien Berns, Hugo M Horlings, Bryan T Hennessy, et al.
Cancer Cell|July 5, 2008
A novel role for a familiar protein in apoptosis induced by proteasome inhibitionDavid J McConkey
Cancer Cell|July 5, 2008
Deregulating EMT and senescence: double impact by a single twistMarjon A Smit, Daniel S Peeper
Cancer Cell|July 5, 2008
In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell propertiesChristoph le Viseur, Marc Hotfilder, Simon Bomken, et al.
Pageof 410